SEI Investments’s Neuropace NPCE Stock Holding History
Bought
Maintained
Sold
Other funds holding NPCE
PCH
SCM
FLAM
O
DCM
VCM
AC
SEI Investments's NPCE Position: Q1 2026 in Review
SEI Investments increased its Neuropace (NPCE) stake by 51% in Q1 2026, buying an estimated $619K and bringing the position to 121,476 shares worth $1.6M. The position accounts for ﹤0.01% of the portfolio, ranked #2120.
SEI Investments first reported a position in NPCE in Q4 2025 and has held it in 2 quarters since. 113 funds tracked by Wall St. Rank hold NPCE as of Q1 2026.
- SEI Investments held 121,476 shares of Neuropace worth $1.6M as of Q1 2026.
- SEI Investments bought 41,233 Neuropace shares in Q1 2026, an estimated $619K.
- Neuropace made up ﹤0.01% of SEI Investments's portfolio in Q1 2026, its #2120 holding.
- SEI Investments first reported a position in Neuropace in Q4 2025 and has held it in 2 quarters since.
- 113 funds tracked by Wall St. Rank held Neuropace as of Q1 2026.
Based on SEI Investments's 13F filing for Q1 2026, filed 13 May 2026.